CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,505,000 | -50.6% | 1,437,441 | 0.0% | 2.41% | -52.2% |
| Q2 2016 | $3,047,000 | -21.8% | 1,437,441 | 0.0% | 5.05% | -31.1% |
| Q1 2016 | $3,895,000 | -3.2% | 1,437,441 | 0.0% | 7.33% | +64.8% |
| Q4 2015 | $4,025,000 | -23.5% | 1,437,441 | 0.0% | 4.45% | -51.9% |
| Q3 2015 | $5,261,000 | -20.4% | 1,437,441 | 0.0% | 9.25% | +34.4% |
| Q2 2015 | $6,612,000 | -48.9% | 1,437,441 | 0.0% | 6.88% | -36.3% |
| Q1 2015 | $12,951,000 | +44.8% | 1,437,441 | 0.0% | 10.80% | +53.3% |
| Q4 2014 | $8,941,000 | +47.4% | 1,437,441 | 0.0% | 7.04% | +25.3% |
| Q3 2014 | $6,066,000 | -27.2% | 1,437,441 | 0.0% | 5.62% | -17.5% |
| Q2 2014 | $8,337,000 | – | 1,437,441 | – | 6.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |